Best Electrolyte Supplements Ranked 2026

Electrolyte Supplement Comparison Table — GLP-1 Fit Rankings

Research Context

GLP-1 medications — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) — create an electrolyte depletion profile that is fundamentally different from general exercise-induced hydration loss. When food intake drops 30–50% under appetite suppression, dietary sodium, potassium, and magnesium intake collapse with it. The result is a predictable side-effect cluster: fatigue, muscle cramps, brain fog, headaches, and dizziness that are not medication side effects per se — they are electrolyte gaps masquerading as medication intolerance.

Most electrolyte products on the market were designed for athletes with normal caloric intake. They are either inadequate for the GLP-1 sodium depletion gap (low-sodium tablets, Liquid IV's 500 mg) or contain sugar that conflicts with GLP-1 glycemic management goals (DripDrop, standard sports drinks). This ranking specifically scores electrolyte protocols for their fit with the GLP-1 user context — sodium adequacy, sugar burden, GI tolerability, magnesium coverage, and practical daily use adherence.

LMNT ranks first because 1000 mg sodium, zero sugar, and a clean ingredient list match the GLP-1 depletion profile most accurately of any single-product option. The magnesium-electrolyte stack ranks second because it adds multi-pathway side-effect coverage — constipation, cramps, and sleep disruption — beyond basic hydration. Precision Hydration PH 1500 is the standout for active GLP-1 users with significant sweat losses. Lower-ranked options are not necessarily bad; they are simply mismatched to the GLP-1 context.

The market for electrolyte supplementation for GLP-1 users has become crowded with simplified claims, but protocol selection requires more than picking the loudest trend. This guide focuses on which protocols actually match the sodium, potassium, and magnesium depletion demands of GLP-1 therapy, caloric restriction, and the associated side-effect cluster and evaluates how each approach performs when evidence quality, adherence cost, safety profile, and implementation complexity are considered together. In 2026, the main differentiator is no longer access to information. It is decision quality under real constraints. People need frameworks that survive normal life, not just ideal weeks.

ProtocolRank uses an evidence-to-execution lens. We review peer-reviewed literature, mechanistic plausibility, practical coaching patterns, and known failure modes. Then we score each protocol by expected return and behavior burden. This method helps avoid false choices where one option appears superior in theory but underdelivers in practice because the routine is too brittle, too expensive, or too difficult to sustain. The best protocol is the one that reliably produces progress while preserving health, performance, and daily function.

Another key point is individual response variability. Baseline fitness, sleep quality, nutrition status, stress load, medication profile, and training history all influence outcomes. A protocol ranked first for the broad population may still be suboptimal for a narrow user profile, and a lower-ranked protocol may perform extremely well when matched to the right constraints. That is why each section includes best-fit guidance, common pitfalls, and escalation logic rather than one-size-fits-all rules.

You should read this ranking as a practical decision tool, not medical advice. High-level recommendations can support planning, but personalized care matters when there are chronic conditions, prescription medications, injury history, hormonal issues, or psychiatric variables. With that context, the sections below provide a structured, evidence-aware way to compare options and choose a protocol you can run consistently over the next quarter.

If this decision includes peptide, TRT, or performance-clinic variables, cross-check provider quality and care-model differences here: Peaked Labs: TRT Provider Comparisons and Peaked Labs: Peptide Provider Pages.

For peptide-specific protocols, visit peakedlabs.com. For longevity deep-dives, visit alivelongevity.com.

How We Ranked These Protocols

Our methodology for electrolyte supplement ranking for GLP-1 users combines four weighted domains: evidence strength, adherence probability, implementation complexity, and downside risk. We use sodium adequacy for GLP-1 depletion context, sugar burden, GI tolerability, magnesium coverage, potassium delivery, cost per effective serving, and daily adherence probability as the primary outcome lens, because those signals capture both short-term response and long-term viability. Protocols were stress-tested for common disruptions such as travel, poor sleep weeks, social obligations, and inconsistent training schedules. If an approach fails under normal variability, it scores lower even when controlled-trial outcomes look strong.

Evidence strength reflects both quality and transferability. Randomized controlled trials and meta-analyses carry the most weight, but mechanism studies and longitudinal cohort data provide context where RCT coverage is limited. We down-rank protocols that rely heavily on anecdote, aggressive extrapolation, or weak surrogate markers. We also assess whether the intervention effect is large enough to matter outside of laboratory conditions. Small theoretical gains with high burden are usually poor real-world bets.

Adherence probability is the most underrated variable in protocol design. People often chase maximal acute effects while ignoring cumulative compliance. To address this, we score friction points explicitly: time cost, social disruption, appetite or recovery strain, monitoring burden, and decision fatigue. Protocols with moderate effect but high repeatability often beat stricter alternatives by month three or month six. Products were penalized when sodium levels fell below 800 mg per serving — the minimum threshold for meaningful GLP-1 dietary sodium gap replacement. Products with significant sugar content were also penalized given the GLP-1 glycemic management context.

Finally, ranking reflects integration potential. A protocol does not operate in isolation. It sits inside sleep, training, nutrition, stress management, and medical context. Options that can integrate with foundational behaviors receive higher scores because they preserve system coherence. In contrast, protocols that force tradeoffs against sleep, recovery, or nutrient adequacy are penalized unless they deliver clearly superior outcomes for a specific user segment.

We separated three electrolyte contexts within the GLP-1 population: (1) daily preventive maintenance for users with reduced dietary sodium, (2) active exercise days where sweat loss compounds the dietary depletion, and (3) acute dehydration events on high-nausea days when oral rehydration is the priority. The optimal protocol can differ across all three.

Palatability and GI tolerability received extra weight in this ranking because GLP-1 users frequently experience nausea, delayed gastric emptying, and GI sensitivity. An electrolyte protocol that triggers nausea or GI discomfort in an already sensitive user fails regardless of its electrolyte profile. Products with clean ingredient lists and minimal artificial sweeteners scored higher for this reason.

Cost per effective serving was assessed relative to GLP-1 use duration — these medications are typically used for 6–24 months. Electrolyte costs over a sustained period are a real consideration. DIY approaches score well on cost but require setup investment that not all users will execute.

Implementation Playbook

• • Step 1: Define a 12-week objective for electrolyte supplementation for GLP-1 users before choosing intensity. Anchor one primary metric, one secondary metric, and one subjective metric so decisions stay objective during plateaus.
• • Step 2: Start at the minimum effective dose. Conservative starts preserve adherence, reduce side effects, and create room for escalation if response is weak after two to four weeks.
• • Step 3: Standardize confounders early. Keep sleep schedule, training volume, hydration, and baseline nutrition stable long enough to identify whether the protocol itself is working.
• • Step 4: Use weekly checkpoints instead of daily emotional decisions. Trend data is more reliable than day-to-day fluctuations in body weight, energy, focus, mood, or recovery.
• • Step 5: Escalate only one variable at a time. Change frequency, dose, or duration separately so you can attribute outcomes accurately and avoid unnecessary complexity.
• • Step 6: Build exit criteria and maintenance rules in advance. Protocols are most valuable when they transition smoothly from intensive phase to sustainable baseline practice.
• • Step 7: Estimate your dietary sodium intake while on GLP-1 — most users consuming 1000–1400 calories are getting 800–1200 mg sodium from food vs a normal 2300+ mg. The gap is 1000+ mg/day.
• • Step 8: Choose a product with at least 800–1000 mg sodium per serving for daily maintenance; scale up for workout days or high-nausea periods.
• • Step 9: Add magnesium glycinate 200–400 mg before bed if you experience cramps, sleep disruption, or constipation — magnesium addresses 4 GLP-1 side effects simultaneously.
• • Step 10: Separate electrolyte supplement timing from GLP-1 injections by 30–60 minutes if experiencing injection-site nausea that is worsened by supplements taken close together.